Analysed ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) News Sources
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
29-06-2026
yahoo.com
Elite Pharmaceuticals Inc (ELTP) Q4 2026 Earnings Call Highlights: Record Revenue Growth and ...
01-07-2026
yahoo.com
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information
13-08-2026
yahoo.com
Elite Pharmaceuticals Inc (ELTP) (Q1 2027) Earnings Call Highlights: Steady Revenue and ...
18-08-2026
yahoo.com
What is the current price of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The current price of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is $0.254.
ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) since the previous trading day is $0.0048.
ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) since the previous trading day is 1.9262%.
What is the most recent average sentiment score for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The most recent average sentiment score for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)?
The most recent sentiment for ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS) is .
SEC-8K** Filing Available For ELITE PHARMACEUTICALS INC (ELTP:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.